End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3222 USD | -2.36% |
|
+2.32% | -20.05% |
Jul. 08 | Tonix Pharmaceuticals Intends to Offer and Sell Shares of its Common Stock | CI |
Jul. 08 | Tonix Pharmaceuticals Plans Stock Offering; Shares Fall After-Hours | MT |
Financials (USD)
Sales 2024 * | 13.92M | Sales 2025 * | 17.78M | Capitalization | 7M |
---|---|---|---|---|---|
Net income 2024 * | -79M | Net income 2025 * | -91M | EV / Sales 2024 * | 0.5 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.39 x |
P/E ratio 2024 * |
-0.02
x | P/E ratio 2025 * |
-0.03
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.99% |
1 day | -2.36% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.21% | 40.77B | |
-11.86% | 33.21B | |
+82.19% | 29.36B | |
-14.25% | 15.7B | |
-7.36% | 13.08B | |
-13.08% | 11.39B | |
+176.65% | 10.47B | |
+5.32% | 9.08B | |
-57.36% | 8.58B |
- Stock Market
- Equities
- TNXP Stock
- TNXP Stock